AOD 9604
AOD 9604 5 mg | 1 vial
- Ingredient:C-terminal fragment of the Human growth hormone
- Manufacturer:Dragon Pharma
- Estimated Delivery : Up to 3 business days
- Free Shipping & Returns : On all orders over $300
AOD 9604 (HGH Lipolytic Fragment) is a peptide fragment of the C-terminus of Human Growth Hormone. It has an ability to stimulate lipolytic (fat burning) and anti-lipogenic activity.AOD9604 (HGH Lipolytic Fragment) acts on the reduction of excessive adipose tissues such as those in the abdominal area, increase in muscle mass, and enhances the lipid content of the body.
AOD 9604 (HGH Lipolytic Fragment) benefits are: Reduces body fat. Mimics the way natural growth hormone regulates fat metabolism. Inhibits lipogenesis that’s the transformation of non-fatty foods into body fat. No adverse effects on blood sugar or growth. Stimulates lipolysis.
AOD 9604 (HGH Lipolytic Fragment) works by mimicking the way natural Growth Hormone regulates fat metabolism but without the adverse effects on blood sugar or growth that is seen with unmodified Growth Hormone.
There is no stipulated dosage of this drug, itās injected the dosage of 300 mcg/day given at bedtime. Inject it into the body fat around the stomach area.
You can use bacteriostatic water or sterile water. Take the lids off both your water and AOD 9604 (HGH Lipolytic Fragment) containers. Use a fresh alcohol swab to clean the area of injection and the rubber stopper of your AOD 9604 (HGH Lipolytic Fragment) bottle and the top of the water vial and allow each to air dry. Fill the insulin syringe with 1 ml water and slowly and carefully inject the syringe of water into the 2 mg bottle of AOD 9604 (HGH Lipolytic Fragment)ā being careful to spray the water onto the sides of the container rather than directly into the powder.
Keep it in the refrigerator or freezer to preserve it until youāre ready to use it. (Usually recommend its use for 3-4 weeks, so do not leave diluted drug for a longer period even in cold environment).









Reviews
There are no reviews yet.